Expression profiles of microRNAs after focal cerebral ischemia/reperfusion injury in rats

Neural Regeneration Research

Volumn 7, Issue 12, 2012, Pages 917-923

  Zhai, Fengguo ^a   Zhang, Xiuping ^a   Guan, Yue ^a   Yang, Xudong ^a   Li, Yang ^a   Song, Gaochen ^a   Guan, Lixin ^a  

^a MUDANJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Bcl 2; Caspase 3; Focal cerebral ischemia; MicroRNA; Neural regeneration

Indexed keywords

CASPASE 3; MICRORNA; MICRORNA 129; MICRORNA 320; MICRORNA 326; MICRORNA 384 5P; MICRORNA 494; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOINFORMATICS; BRAIN ISCHEMIA; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; MICROARRAY ANALYSIS; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; WESTERN BLOTTING;

EID: 84861416633     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2012.12.007     Document Type: Article

References (41)

1. Mattson MP, Duan W, Pedersen WA, et al. Neurodegenerative disorders and ischemic brain diseases. Apoptosis. 2001;6(1-2): 69-81.
2. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215-233.
3. Chen K, Rajewsky N. The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 2007;8(2): 93-103.
4. Filip A. MiRNA-new mechanisms of gene expression control. Postepy Biochem. 2007;53(4):413-419.
5. Kosik KS. The neuronal microRNA system. Nat Rev Neurosci. 2006;7(12):911-920.
6. Redell JB, Liu Y, Dash PK. Traumatic brain injury alters expression of hippocampal microRNAs: potential regulators of multiple pathophysiological processes. J Neurosci Res. 2009;87(6):1435-1448.
7. Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004;23(20):4051-4060.
8. Wienholds E, Plasterk RH. MicroRNA function in animal development. FEBS Lett. 2005;579(26):5911-5922.
9. Nicoloso MS, Calin GA. MicroRNA involvement in brain tumors: from bench to bedside. Brain Pathol. 2008;18(1):122-129.
10. Hébert SS, Horré K, NicolaïL, et al. Loss of microRNA cluster miR29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA. 2008;105(17):6415-6420.
11. Kim J, Inoue K, Ishii J, et al. A microRNA feedback circuit in midbrain dopamine neurons. Science. 2007;317(5842): 1220-1224.
12. Kuhn DE, Nuovo GJ, Martin MM, et al. Human chromosome 21-derived miRNAs are overexpressed in Down syndrome brains and hearts. Biochem Biophys Res Commun. 2008;370(3): 473-477.
13. Beveridge NJ, Tooney PA, Carroll AP, et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet. 2008;17(8):1156-1168.
14. Dharap A, Bowen K, Place R, et al. Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab. 2009;29(4):675-687.
15. Jeyaseelan K, Lim KY, Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke. 2008;39(3):959-966.
16. Liu DZ, Tian Y, Ander BP, et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab. 2010;30(1):92-101.
17. Yin KJ, Deng Z, Huang H, et al. miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis. 2010;38(1):17-26.
18. Soriano MA, Tessier M, Certa U, et al. Parallel gene expression monitoring using oligonucleotide probe arrays of multiple transcripts with an animal model of focal ischemia. J Cereb Blood Flow Metab. 2000;20(7):1045-1055.
19. Vemuganti R, Bowen KK, Dhodda VK, et al. Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia. J Neurochem. 2002;83(5):1072-1086.
20. Lu A, Tang Y, Ran R, et al. Genomics of the periinfarction cortex after focal cerebral ischemia. J Cereb Blood Flow Metab. 2003;23(7):786-810.
21. Du X, Tang Y, Xu H, et al. Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: Comparisons to ischemic stroke, migraine, and Tourette syndrome. Genomics. 2006;87(6): 693-703.
22. Dharap A, Vemuganti R. Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J Neurochem. 2010;113(6):1685-1691.
23. Kapadia R, Tureyen K, Bowen KK, et al. Decreased brain damage and curtailed inflammation in transcription factor C/EBP-β knockout mice following transient focal cerebral ischemia. J Neurochem. 2006;98(6):1718-1731.
24. Yan YP, Sailor KA, Lang BT, et al. Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia. J Cereb Blood Flow Metab. 2007;27(6): 1213-1224.
25. Kawaguchi M, Drummond JC, Cole DJ, et al. Effect of isoflurane on neuronal apoptosis in rats subjected to focal cerebral ischemia. Anesth Analg. 2004;98(3):798-805.
26. Yuan J. Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. Apoptosis. 2009;14(4):469-477.
27. Gustafsson AB, Gottlieb RA. Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol. 2007;292(1):C45-C51.
28. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates and functions during apoptosis. Annu Rev Biochem. 1999;68:383-424.
29. Cohen GM. Caspases: The executioners of apoptosis. Biochem J. 1997;326(Pt 1):1-16.
30. Letai A. PharMCAOlogical manipulation of Bcl-2 family members to control cell death. J Clin Invest. 2005;115(10):2648-2655.
31. Fischer U, Schulze-Osthoff K. New approaches and therapeutics targeting apoptosis in disease. Pharmacol Rev. 2005;57(2): 187-215.
32. Jovanovic M, Hengartner MO. miRNAs and apoptosis: RNAs to die for. Oncogene. 2006;25(46):6176-6187.
33. Tang Y, Zheng J, Sun Y, et al. MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int Heart J. 2009; 50(3):377-387.
34. Schickel R, Boyerinas B, Park SM, et al. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene. 2008;27(45):5959-5974.
35. Kuhn DE, Martin MM, Feldman DS, et al. Experimental validation of miRNA targets. Methods. 2008;44(1):47-54.
36. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
37. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84-91.
38. Zierath D, Hadwin J, Savos A, et al. Anamnestic recall of stroke-related deficits: an animal model. Stroke. 2010;41(11): 2653-2660.
39. Calloni RL, Winkler BC, Ricci G, et al. Transient middle cerebral artery occlusion in rats as an experimental model of brain ischemia. Acta Cir Bras. 2010;25(5):428-433.
40. Buller B, Liu XS, Wang XL, et al. miR-21 protects neurons from ischemic death. FEBS J. 2010;277(20):4299-4307.
41. Kao TK, Ou YC, Kuo JS, et al. Neuroprotection by tetramethylpyrazine against ischemic brain injury in rats. Neurochem Int. 2006;48(3):166-176.